Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,218,479 papers from all fields of science
Search
Sign In
Create Free Account
trametinib dimethyl sulfoxide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Narrower (1)
Mekinist
Broader (1)
trametinib
trametinib 2 MG Oral Tablet [Mekinist]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma.
Giuliana Carlos
,
Rachael M Anforth
,
+4 authors
P. Fernández-Peñas
JAMA dermatology
2015
Corpus ID: 19633465
IMPORTANCE The cutaneous adverse effects of the BRAF inhibitors vemurafenib and dabrafenib mesylate in the treatment of…
Expand
2015
2015
MEK inhibitor-induced dusky erythema: characteristic drug hypersensitivity manifestation in 3 patients.
Urvi J. Patel
,
L. Cornelius
,
M. Anadkat
JAMA dermatology
2015
Corpus ID: 27865462
IMPORTANCE MEK inhibitors are being evaluated in clinical trials for treatment of different malignant neoplasms; trametinib…
Expand
2013
2013
Pomalidomide, dabrafenib mesylate, and trametinib dimethyl sulfoxide.
D. Hussar
,
Jessica L Kaminski
Journal of the American Pharmacists Association
2013
Corpus ID: 30365027
2012
2012
Trametinib dimethyl sulfoxide
D. Cosgrove
Drugs of the future
2012
Corpus ID: 74809491
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required